FDA Investigator: Holly Brevig
- Holly Brevig first started conducting FDA inspections in 2019, with the last inspection in 2024. Over that time, Holly Brevig has conducted 8 inspections at 8 companies across 8 sites.
Get Holly Brevig's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Ten23 Health Valais AG, Visp | 2024
Out-of-stock
Holly Brevig
Human Drugs Form 483
FDA 483 F. Hoffmann-La Roche AG, Basel Town | 2024
Out-of-stock
Holly Brevig
Human Drugs Form 483
FDA 483 Boehringer Ingelheim RCV GmbH & Co KG, Vienna | 2023
Out-of-stock
Holly Brevig
Human Drugs Form 483
FDA 483 Takeda Pharmaceutical Company Limited, Hikari | 2023
Out-of-stock
Holly Brevig
Human Drugs Form 483
FDA 483 Kedrion Biopharma Inc., Melville | 2019
Out-of-stock
Holly Brevig
Biologic Form 483
FDA 483 Emergent Biodefense Operations Lansing LLC, Lansing | 2019
Out-of-stock
Holly Brevig
Biologic Form 483
Co-Investigators (15)
- Thuy T. Nguyen, FDA Investigator
- Cassandra L. Abellard, FDA Investigator
- Raeann R. Wu, FDA Investigator
- Laurimer Kuilan-Torres, FDA Investigator
- Vidya B. Pai, FDA Investigator
- Bingchen Du, FDA Investigator
- Hector A. Carrero, FDA Investigator
- Pankaj H. Amin, FDA Investigator
- Linda Thai, FDA Investigator
- Malgorzata G. Norton, FDA Investigator
- Timothy M. Martin, FDA Investigator
- David E. Bailey, FDA Investigator
- Christine Harman, FDA Investigator
- Jennifer L. Bridgewater, FDA Investigator
- Steven C. Derrick, FDA Investigator